Drug Profile
Research programme: stem cell modulators - Fate Therapeutics
Alternative Names: FT 4145Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator The Scripps Research Institute
- Developer Fate Therapeutics
- Class Biological proteins; Small molecules; Wnt proteins
- Mechanism of Action Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Heart failure; Musculoskeletal disorders; Neurological disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Musculoskeletal-disorders in USA (Injection)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neurological-disorders in USA (Injection)
- 04 Nov 2017 No recent reports of development identified for research development in Heart-failure in USA